Decibel Therapeutics Inc.

NASDAQ: DBTX · Real-Time Price · USD
4.91
-0.04 (-0.81%)
At close: Sep 22, 2023, 10:00 PM

Decibel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
34.61M 36.45M
Short-Term Investments
69.95M 112.29M
Long-Term Investments
n/a 13.55M
Other Long-Term Assets
924K 1.13M
Receivables
n/a 11.4M
Inventory
n/a n/a
Other Current Assets
3.47M 4.04M
Total Current Assets
108.03M 164.19M
Property-Plant & Equipment
14.42M 5.61M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
15.34M 20.29M
Total Assets
123.37M 184.48M
Account Payables
1.06M 4.01M
Deferred Revenue
n/a n/a
Short-Term Debt
3.59M 213K
Other Current Liabilities
17.79M 16.31M
Total Current Liabilities
22.44M 20.54M
Long-Term Debt
10.47M 4.21M
Other Long-Term Liabilities
8.67M 18.04M
Total Long-Term Liabilities
19.14M 22.25M
Total Liabilities
41.58M 42.79M
Total Debt
14.05M 213K
Common Stock
25K 25K
Retained Earnings
-277.52M -214.51M
Comprehensive Income
-223K -132K
Shareholders Equity
81.79M 141.69M
Total Investments
69.95M 125.84M